CD7 CAR-T: a bridge to transplant in AML

被引：0
|
作者：
Mamonkin, Maksim [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
BLOOD | 2025年 / 145卷 / 10期
关键词：
THERAPY; 1ST-IN-HUMAN; CELLS;
D O I：
10.1182/blood.2024027442
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Lu et al1 report early results from a phase 1 study of autologous CD7 chimeric antigen receptor-modified T cells (CD7 CAR-T) in patients with acute myeloid leukemia (AML). The authors describe the safety and preliminary efficacy of CD7 CAR-T, which induced disease remission in most patients. However, the responses were durable only in those who received subsequent allogeneic hematopoietic stem cell transplant (alloHSCT).
引用
收藏
页码：995 / 996
页数：2
相关论文
共 50 条
  • [1] Targeting AML with Naturally Occurring CD7 Negative T Cells Expressing CD7 CAR
    Thanekar, Unmesha
    Nevitt, Chris
    Zoine, Jaquelyn T.
    Mamonkin, Maksim
    Umeda, Masayuki
    Klco, Jeffery
    Velasquez, M. Paulina
    MOLECULAR THERAPY, 2024, 32 (04) : 121 - 122
  • [2] RELEVANT STUDIES ON CYTOKINES LEVEL AND CAR-T EXPANSION ASSOCIATED TO CD7 CAR-T THERAPY
    Wang, Dongchu
    Wang, Hui
    Chen, Man
    BONE MARROW TRANSPLANTATION, 2024, 59 : 207 - 208
  • [3] Relevant Studies on Cytokines Level and CAR-T Expansion Associated to CD7 CAR-T Therapy
    Wang, Dongchu
    Wang, Hui
    BLOOD, 2023, 142
  • [4] CD7 CAR-T Therapy for Treating CD7-Positive Hematological Malignancies
    Lu, Peihua
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S73 - S74
  • [5] Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
    Xie, Leling
    Gu, Runxia
    Yang, Xue
    Qiu, Shaowei
    Xu, Yingxi
    Mou, Junli
    Wang, Ying
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    BLOOD, 2022, 140 : 4535 - 4535
  • [6] Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
    Xie, Leling
    Gu, Runxia
    Yang, Xue
    Qiu, Shaowei
    Xu, Yingxi
    Mou, Junli
    Wang, Ying
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    HUMAN GENE THERAPY, 2023, 34 (23-24) : 1257 - 1272
  • [7] Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia
    Zhang, Xian
    Zhang, Gailing
    Li, Wenqian
    Qiu, Liyuan
    Wang, Dongchu
    Yang, Junfang
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2021, 138
  • [8] Intracellular retention of TCRαβ/CD3 and CD7 to generate novel allogeneic CAR-T cells targeting CD7 for treating T-cell malignancies
    Li, Jun
    Liu, Kaichun
    Fu, Jianmin
    Chen, Shanshan
    Zhang, Yinhang
    Xu, Guanggui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] CD7 CAR-T Therapy Followed By a Second Transplant for T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients Who Relapsed after a Prior Transplant
    Cao, Xingyu
    Zhang, Jianping
    Lu, Yue
    Zhao, Yanli
    Liu, Deyan
    Xiong, Min
    Wei, Zhijie
    Zhou, Jiarui
    Zhang, Xian
    Yang, Junfang
    Liu, Hongxing
    Lu, Peihua
    BLOOD, 2023, 142
  • [10] CD7 CAR: sword and shield
    Velasquez, M. Paulina
    Mamonkin, Maksim
    BLOOD, 2022, 140 (04) : 293 - 294
12345